Know what’s really happening at
Candid Health before you sign on.
- On the roadmap
- AI Healthcare
- Revenue Cycle Management
Candid Health builds autonomous revenue cycle software that pushes claims through payment with no manual touch — customers report over 95% touchless claim rates. Its July 2026 Series D, led by Sixth Street Growth, tripled the valuation set just 17 months earlier.
How we do it.
Most "AI market intel" is a summarized crawl of press releases. This Altis research is built from our knowledge graph of sector expert calls, synthesized with public sources.
Candid Health
- Series D led by Sixth Street Growth (July 2026)
- $120M
- Total equity funding
- $219.8M
- Series C led by Oak HC/FT (Feb 2025)
- $52.5M
- YoY contracted run-rate revenue growth (2025)
- 190%
- YoY net dollar retention (2025)
- 180%
- Customer base
- more than 200 healthcare organizations
- Customer-reported automation level
- over 95% touchless claim rates
- Founded, San Francisco
- 2019
Press reported
Altis Verified
What's in the report
Most "AI market intel" is a summarized crawl of press releases. This is what customers, competitors, and former employees actually told us.
Market Overview
Market structure, where the company sits, and growth drivers.
- market map
- AI Healthcare landscape
- AI Healthcare growth rate
- CAGR
Total Addressable Market
Bottom-up TAM / SAM / SOM.
- Candid Health TAM
- AI Healthcare market size
- market opportunity
Company Overview
What the company does and how it operates.
- what does Candid Health do
- Candid Health product
- business model
Product / Go-to-Market
Product, GTM motion, ICP, and who buys.
- Candid Health customers
- who uses Candid Health
- Candid Health ICP
- go-to-market
Competitive Dynamics
The Altis Market Map and the Altis Win-Rate Index.
- Candid Health competitors
- Candid Health alternatives
- who competes with Candid Health
- Candid Health win rate
Customer Signals
Retention, satisfaction, and win/loss signals.
- Candid Health reviews
- Candid Health NRR
- Candid Health churn
- current customers
- switching costs
Investment Debates
Investment thesis, moat, bull/bear, and key risks.
- Candid Health investment thesis
- Candid Health moat
- bull case bear case
- Candid Health risk factors
Monetization & Financials
Business model, revenue model, and unit economics.
- Candid Health ARR
- Candid Health revenue
- Candid Health valuation
- unit economics
Team and culture
Founders, leadership, and org.
- Candid Health founders
- Candid Health CEO background
- leadership team
- headcount
Trusted by
Ready to see the full picture?
Based on public reporting and company disclosures as of July 2026.